Scenario catalog
Roadmap · late 2026DSM-5-TR · F40.230

Blood, needle, and hospital phobia

Specific phobia · blood-injection-injury subtype

Intense fear of medical settings: hospitals, white coats, needles, blood draws, procedures. The hallmark is a vasovagal response — a blood-pressure drop that can lead to fainting.

Prevalence
3–4% of adults · characteristic vasovagal drop
Typical course
6–10 VR sessions + real sessions with a healthcare partner

Why VR for this phobia?

In-vivo exposure is hard to arrange: it needs access to a partner hospital, and a patient with intense fear usually avoids it. VR is the only realistic way to run this exposure inside a private office.

VR hierarchy · 5 graded levels

Each level should be completed with SUDS in the target range across at least two consecutive sessions before advancing. The most common mistake is moving up levels too fast because the scenario is so easy to change.

  1. 1

    Hospital entrance, outpatient waiting room

    SUDS target: ≤4

  2. 2

    Exam room with instruments visible (not in use)

    SUDS target: ≤5

  3. 3

    Draw station with a loaded syringe in view

    SUDS target: ≤5

  4. 4

    Simulated injection (the patient decides)

    SUDS target: ≤4

  5. 5

    Operating room with light surgical prep

    SUDS target: ≤3

Clinical notes

The ONLY phobia with a characteristic vasovagal response (bradycardia and a blood-pressure drop rather than tachycardia). Apply 'applied tension' before exposure. VR doesn't trigger the full vasovagal response but it does trigger the cognitive one — useful for preparing in-vivo work. Scenarios are on the roadmap.

Specific contraindications

  • Recurrent vasovagal syncope: requires a prior applied-tension protocol
  • Severe baseline hypotension

Is Blood, needle, and hospital phobia a scenario you need?

Book a demo and tell us — your input weighs on the quarterly roadmap. On Enterprise we can build a custom scenario for you.

VRET is professional clinical-support software, not a certified medical device. Supervision, indication, and application remain the responsibility of the licensed clinician in charge.